NCT06533904

Brief Summary

The goal of this double blinded randomized control trial is to learn if percutaneous cryoablation of traumatic rib fractures improves outcomes. The main questions it aims to answer are: Does percutaneous cryoablation improve short and long term pain scores? Does percutaneous cryoablation improve short and long term respiratory mechanics? Does percutaneous cryoablation improve long term quality of life? Does percutaneous cryoablation decrease delirium? Researchers will compare cryoablation to standard multimodal pain therapy to see if this impacts respiratory recovery. Participants will undergo randomization, percutaneous cryoablative procedure, and participate in tests at pre-determined intervals to evaluate their pulmonary recovery.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
22mo left

Started Sep 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 30, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 1, 2024

Completed
2.1 years until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2028

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2028

Last Updated

February 9, 2026

Status Verified

February 1, 2026

Enrollment Period

1.8 years

First QC Date

July 30, 2024

Last Update Submit

February 5, 2026

Conditions

Keywords

TraumaRespiratory FailureRespiratory DistressRespiratory InsufficiencyRib FracturesChest Wall TraumaPercutaneous CryoablationMultimodal Pain TherapyMultimodal Pain Regimen

Outcome Measures

Primary Outcomes (5)

  • Pain Score: Numeric Pain Scale

    Short and Long Term Pain Scores. Range from 0 to 10 where 0 is no pain and 10 is most severe and worse outcome.

    Through study completion, up to 1 year

  • Rate of abnormal respiratory mechanics: Incentive Spirometry

    Through study completion, up to 1 year

  • Rate of abnormal respiratory mechanics: Pulmonary Function Tests

    Short and Long Term Respiratory Mechanics. Pulmonary Function Tests will specifically measure Forced Expiratory Volume in 1 second (FEV1) and Forced Vital Capacity (FVC)

    Through study completion, up to 1 year

  • Rate of delirium: Confusion Assessment Method (CAM) Score

    The score ranges from 0 to 19. Where higher scores indicate more severe delirium and low scores indicate less severe or no delirium

    Through study completion, up to 1 year

  • Quality of Life on Survey

    Long Term Quality of Life

    Through study completion, up to 1 year

Secondary Outcomes (9)

  • Rate of Pneumonia

    Through study completion, up to 1 year

  • Rate of need for Intubation/Mechanical Ventilation

    Through study completion, up to 1 year

  • Rate of need for tracheostomy

    Through study completion, up to 1 year

  • Number of Ventilatory Days

    Through study completion, up to 1 year

  • ICU Length of Stay

    Through study completion, up to 1 year

  • +4 more secondary outcomes

Study Arms (2)

Standard multi-modal pain regimen alone

PLACEBO COMPARATOR
Other: Multi-modal pain regimen

Standard multi-modal pain regimen with percutaneous cryoablation

EXPERIMENTAL
Procedure: Percutaneous Cryoablation of Intercostal NervesOther: Multi-modal pain regimen

Interventions

Percutaneous Cryoablation of Intercostal Nerves

Standard multi-modal pain regimen with percutaneous cryoablation

Standard rib fracture protocol including cyclooxygenase inhibitors, anti-neuropathic, muscle relaxers, short term anesthesia interventions (percutaneous block, epidural)

Standard multi-modal pain regimen aloneStandard multi-modal pain regimen with percutaneous cryoablation

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \> 18 years old
  • \> 2 rib fractures
  • Verbal Pain score \> 5
  • Incentive Spirometry \< 60% of predicted

You may not qualify if:

  • Isolated Fractures of Ribs 1-3 and/or 10-12
  • Posterior Rib Fracture \< 4 cm from costovertebral joint
  • Sternal, Clavicle, Scapula Fracture
  • Thoracic Spinal Fracture of any type
  • Open Abdominothoracic Surgery
  • Unstable Spine
  • Extensive Subcutaneous Emphysema
  • BMI \> 35
  • Plan for Rib Plating
  • Chronic Opioid Use
  • Prior to study enrollment: Intubated, Traumatic Brain Injury, Dementia, Cognitive Impairment, Encephalopathy
  • Coagulopathy, Shock at time of ablation
  • Inability to participate in activities of daily living prior to injury
  • Home O2 use prior to trauma
  • Inhalation Injury
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Loma Linda University Health

Loma Linda, California, 92354, United States

Location

MeSH Terms

Conditions

Wounds and InjuriesRib FracturesRespiratory InsufficiencyChest PainRespiratory Distress SyndromeDyspnea

Condition Hierarchy (Ancestors)

Fractures, BoneThoracic InjuriesRespiration DisordersRespiratory Tract DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsLung DiseasesSigns and Symptoms, Respiratory

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Patients will be randomized to standard multi-modal pain regimen with percutaneous cryoablation versus standard multi-modal pain regimen alone.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 30, 2024

First Posted

August 1, 2024

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

July 1, 2028

Study Completion (Estimated)

July 1, 2028

Last Updated

February 9, 2026

Record last verified: 2026-02

Locations